UNITED STATES OF AMERICA, PETITIONER V. WADE BAKER, ET AL. No. 87-1180 In the Supreme Court of the United States October Term, 1987 The Solicitor General, on behalf of the United States of America, petitions for a writ of certiorari to review the judgment of the United States Court of Appeals for the Ninth Circuit in this case. Petition for a Writ of Certiorari to the United States Court of Appeals for the Ninth Circuit TABLE OF CONTENTS Question Presented Opinions below Jurisdiction Statement Reasons for granting the petition Conclusion OPINIONS BELOW The opinion of the court of appeals (App., infra, 1a-13a) is reported at 817 F.2d 560. The opinion of the district court (App., infra, 14a-15a) is unreported. JURISDICTION The decision of the court of appeals was entered on May 18, 1987. A petition for rehearing with suggestion of rehearing en banc was denied on October 15, 1987 (App., infra, 16a). The jurisdiction of this Court is invoked under 28 U.S.C. 1254(1). QUESTION PRESENTED Whether the discretionary function exception to the Federal Tort Claims Act, 28 U.S.C. 2680(a), bars respondents' claim that the government was negligent in its 1963 decision to license Lederle Laboratories' Sabin oral polio vaccine. STATEMENT 1. Respondent Wade Baker contracted poliomyelitis from his nephew, who had recently been innoculated with Orimune, a Sabin oral polio vaccine manufactured by Lederle Laboratories. This vaccine contains a "shed virus" that spreads to, and generally immunizes, those who come into close contact with the vaccinated person. App., infra, 2a. Baker and his wife filed suit in federal district court alleging that the United States is liable for his injuries under the Federal Tort Claims Act (FTCA) because the government was negligent in licensing Orimune on June 25, 1963. Respondents claimed that the Department of Health, Educaiton and Welfare (HEW (now the Department of Health and Human Services)) had negligently failed to follow its own regulations in supervising Lederle's testing of the vaccine prior to licensing. Specifically, respondents alleged that HEW was negligent in failing (1) to require Lederle to test adequately the safety and effectiveness of the Sabin poliovirus strain prior to licensing in 1963; (2) to require Lederle to test adequately the vaccine itself prior to licensing in 1963; and (3) to require Lederle to test the shed virus for safety and efficacy and to obtain a license for its manufacture. App., infra, 2a-3a. 2. The government moved to dismiss the suit as barred by the discretionary function exception to liability under the FTCA, 28 U.S.C. 2680(a). The district court granted the motion, holding (App., infra, 14a) that "the present case is analogous to United States v. S.A. Empressa de Viacao Aerea Rio Grandense (Varig Airlines), (467 U.S. 797 (1984),) and is therefore barred by the discretionary function exception to the Federal Tort Claims Act." The court of appeals reversed (App., infra, 1a-13a), relying in part on two pre-Varig Airlines cases, Griffin v. United States, 500 F.2d 1059 (3rd Cir. 1974) and Loge v. Unied States, 662 F.2d 1268 (8th Cir. 1981), cert. denied, 456 U.S. 944 (1982). The court distinguished Varig Airlines, where "the mandatory regulations governed the conduct of the airline, not the government" (App., infra, 12a). It said that in this case, by contrast, the agency "may not issue a license for manufacturing poliovirus vaccine unless the relevant test data has been submitted," and that the agency thus has a mandatory duty to require the submission of those data (ibid.). While acknowledging that "(t)he issue * * * pose(d) is a close and difficult one" (id. at 9a), the court stated that it was unwilling to apply the discretionary function exception to respondents' allegations of "a negligent failure to obey a mandatory regulatory command" (id. at 12a). REASONS FOR GRANTING THE PETITION There is a direct conflict between the decision of the court of appeals and a recent decision by the Third Circuit in Berkovitz v. United States, 822 F.2d 1322 (1987), cert. granted, No. 87-498 (Jan. 11, 1988). Because of this conflict and of the importance of the question presented, we acquiesced in the petition for certiorari filed in Berkovitz. The instant case should accordingly be held for disposition as appropriate in light of the decision in Berkovitz. On June 30 1987, just over a month after the court of appeals' decision in this case, a dividend panel of the Third Circuit held in Berkovitz that the discretionary function exception does apply to the government's 1963 decision to license the Lederle oral polio vaccine. The plaintiffs in Berkovitz alleged that the government issued a license for Lederle's Sabin poliovirus strain when it had not been subjected to all required testing and did not comply with all regulatory standards (822 F.2d at 1324). The court of appeals stated that the question presented was whether the government had a nondiscretionary duty to ensure that Lederle followed regulatory standards in the production and distribution of the Sabin polio vaccine (id. at 1329). The court of appeals canvassed the applicable regulations and noted that, while they required the manufacturer to perform certain tests and submit qualifying results to the government, they did not require the government to do anything (id. at 1329-1332). The court concluded that, as in Varig Airlines, the onus was on the manufacturer to comply with applicable safety standards, while the role of the government agency was "'merely to police the conduct of private individuals by monitoring their compliance with (the applicable) regulations'" (id. at 1332 (quoting 467 U.S. at 815)). Because "neither the statute nor the regulations mandate the (agency's) choice of how to secure Lederle's compliance" (822 F.2d at 1332), the court concluded that the discretionary function exception bars suit for alleged negligence in the government's performance of that role. There is, thus, a direct conflict between the Ninth Circuit's holding in this case that the government's decision to license the Sabin vaccine was not a discretionary function, and the Third Circuit's decision in Berkovitz that it was. /1/ In light of this conflict and the importance of the question presented, we acquiesced in the petition for certiorari filed by the plaintiffs in Berkovitz. /2/ The Court has now granted certiorari in Berkovitz. We therefore suggest that the Court hold this case pending a decision on the merits in Berkovitz. CONCLUSION The petition for a writ of certiorari should be held and disposed of as sppropriate in light of the decision in Berkovitz v. United States, cert. granted, No. 87-498 (Jan. 11, 1988). Respectfully submitted. CHARLES FRIED Solicitor General JANUARY 1988 /1/ In Berkovitz, the court of appeals noted the decision in this case and stated that "Berkovitz's complaint can be read as alleging a similar failure to require submission of test data." The Third Circuit expressly declined to follow the Ninth Circuit panel's determination on this issue, stating (822 F.2d at 1330 n.6): We do not agree, however, that the (agency) is under a duty to require submission of test data. Rather, the duty to submit test data rests with the manufacturer. See 21 C.F.R. Sections 601.2, 610.1, 630.10(b)(4) (1987). /2/ We have furnished respondents with a copy of our acquiescence in Berkovitz and will furnish petitioners in that case with a copy of the instant petition. APPENDIX